Evolution Wealth Advisors, LLC Global Blood Therapeutics, Inc. Transaction History

Evolution Wealth Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$24.9 - $40.26 $3,610 - $5,837	-145 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$25.48 - $37.34 $5,631 - $8,252	-221 Reduced 60.38%	145 $4,000
Q1 2021 Apr 20, 2021	SELL	$38.94 - $50.85 $2,102 - $2,745	-54 Reduced 12.86%	366 $15,000
Q3 2020 Oct 15, 2020	BUY	$52.76 - $74.49 $2,690 - $3,798	51 Added 13.82%	420 $23,000
Q2 2020 Jul 27, 2020	SELL	$48.73 - $81.82 $3,313 - $5,563	-68 Reduced 15.56%	369 $23,000
Q1 2020 Apr 22, 2020	BUY	$41.72 - $87.2 $3,379 - $7,063	81 Added 22.75%	437 $22,000
Q4 2019 Feb 03, 2020	BUY	$45.7 - $81.86 $15,172 - $27,177	332 Added 1383.33%	356 $28,000
Q3 2019 Nov 12, 2019	SELL	$45.35 - $57.91 $11,564 - $14,767	-255 Reduced 91.4%	24 $1,000
Q2 2019 Jul 12, 2019	BUY	$52.6 - $63.29 $14,675 - $17,657	279 New	279 $15,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.